Receptor News and Research

RSS

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

26 Aug 2022

Study explores a potential new therapeutic approach for triple negative breast cancer treatment

Researchers are exploring a potential new therapeutic approach for triple negative breast cancer treatment.

26 Aug 2022

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

A new study reported a single-cell adenovirus (SC-Ad) which replicates the antigen genes substantially without producing infectious progeny.

26 Aug 2022

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

26 Aug 2022

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

Researchers map the proteomes of peripheral blood neutrophils isolated from hospitalized COVID-19 patients using high-resolution LC-MS.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

A recent study investigated ‘targets’ in the poxvirus and identified the protein residues active in MPV, following which eight potential anti-viral drugs were proposed.

25 Aug 2022

Severe COVID-19 increases risk of future cardiovascular events

A recent study determines the relationship between COVID-19 severity and risk of subsequent cardiovascular events in a large cohort.

24 Aug 2022

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Targeting Na+/K+ ATPase alpha 1 (ATP1A1) subunit proteins could help identify novel therapies for addressing blood clots and thrombosis, according to a new study by Marshall University researchers.

24 Aug 2022

Researchers explore ocular lesions in monkeypox virus infections

Researchers highlighted the virological and clinical characteristics of monkeypox virus (MPXV) infections with ocular involvement.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Surprising culprit contributes significantly to the brain destruction after stroke or TBI

In the aftermath of a stroke or TBI, a group of amino acids that typically support brain function contribute significantly to the brain destruction that can follow both these injuries, scientists report.

23 Aug 2022

Investigating the missing link between COVID-19 and anosmia

A new study evaluated how SARS-CoV-2 infection leads to anosmia via chromatin structure disruption and OR dysregulation. For this purpose, publicly available Hi-C data of OSNs of SARS-CoV-2-infected and control human subjects were used.

23 Aug 2022

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

A new study addresses the important question of how the SARS-CoV-2 virus would evolve in the future to be able to escape diverse and broadly neutralizing antibodies.

23 Aug 2022

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

Researchers demonstrated DNA origami as a potential platform to display the SARS-CoV-2 receptor-binding domain.

23 Aug 2022

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

Researchers explored the risk factors correlated with post-acute sequelae of SARS-CoV-2.

23 Aug 2022

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

A new study reports that hybrid immunity induced by vaccination and previous infection induces SARS-CoV-2-specific tissue-resident T-cells in the nasal cavity.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Scientists begin phase 2 clinical trials of lupus pill

Lupus is an autoimmune disease that attacks organs and can be fatal. There's no cure, so current treatments aim to limit damage and ameliorate symptoms.

22 Aug 2022

Receptor News and Research

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Study explores a potential new therapeutic approach for triple negative breast cancer treatment

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

Severe COVID-19 increases risk of future cardiovascular events

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Researchers explore ocular lesions in monkeypox virus infections

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Surprising culprit contributes significantly to the brain destruction after stroke or TBI

Investigating the missing link between COVID-19 and anosmia

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Scientists begin phase 2 clinical trials of lupus pill

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News